Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Early-Onset Neonatal Sepsis: Inflammatory Biomarkers and MicroRNA as Potential Diagnostic Tools in Preterm Newborns

P. Janec, M. Mojžíšek, M. Pánek, M. Haluzík, J. Živný, J. Janota

. 2023 ; 69 (5-6) : 173-180. [pub] -

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24008638

Grant support
NU20-07-00109 Agentura Pro Zdravotnický Výzkum České Republiky

Mortality and morbidity of newborns with sepsis can be improved by early and accurate diagnosis and targeted therapy. To evaluate the early molecular events associated with inflammation and infection, we evaluated markers of endothelial activation and injury and circulating plasma miRNAs in preterm newborns with sepsis. The study group consisted of newborns with gestational age ≤ 32 weeks, with culture-positive early-onset neonatal sepsis (sepsis group, N = 8), and as a control group, we enrolled newborns without sepsis (control group, N = 12). Soluble markers of inflammation were measured using Luminex-based multiplex assay. Platelet-free plasma RNA was used to construct the library for miRNA sequencing analysis. Normalized counts were calculated and used to measure differential expression of individual detected miRNAs. We found a significant increase of interleukin 18 (IL-18) in the cord blood of the sepsis group (mean ± SEM, 104.7 ± 30.4 pg/ml vs 52.7 ± 5.6 pg/ml, P = 0.02). In peripheral blood of sepsis group patients, we found a significant increase of VEGF-A compared to controls (196.0 ± 70.5 pg/ml vs 59.6 ± 8.5 pg/ml, P = 0.02). In the cord blood plasma, eight miRNAs had significantly differential expression (P < 0.05), four miRNAs were up-regulated and four miRNAs down-regulated. In peripheral blood plasma, all nine miRNAs with significant differential expression were up-regulated. In conclusion, in early-onset neonatal sepsis, IL-18 and VEGF-A might be considered in diagnostic workup. Early-onset sepsis in preterm newborns is associated with significant changes in the circulating miRNA pattern.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24008638
003      
CZ-PrNML
005      
20250121094620.0
007      
ta
008      
240509s2023 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.14712/fb2023069050173 $2 doi
035    __
$a (PubMed)38583178
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Janec, Petr $u Department of Neonatology, Masaryk Hospital Ústí nad Labem, Krajská zdravotní, Ústí nad Labem, Czech Republic $7 xx0109414
245    10
$a Early-Onset Neonatal Sepsis: Inflammatory Biomarkers and MicroRNA as Potential Diagnostic Tools in Preterm Newborns / $c P. Janec, M. Mojžíšek, M. Pánek, M. Haluzík, J. Živný, J. Janota
520    9_
$a Mortality and morbidity of newborns with sepsis can be improved by early and accurate diagnosis and targeted therapy. To evaluate the early molecular events associated with inflammation and infection, we evaluated markers of endothelial activation and injury and circulating plasma miRNAs in preterm newborns with sepsis. The study group consisted of newborns with gestational age ≤ 32 weeks, with culture-positive early-onset neonatal sepsis (sepsis group, N = 8), and as a control group, we enrolled newborns without sepsis (control group, N = 12). Soluble markers of inflammation were measured using Luminex-based multiplex assay. Platelet-free plasma RNA was used to construct the library for miRNA sequencing analysis. Normalized counts were calculated and used to measure differential expression of individual detected miRNAs. We found a significant increase of interleukin 18 (IL-18) in the cord blood of the sepsis group (mean ± SEM, 104.7 ± 30.4 pg/ml vs 52.7 ± 5.6 pg/ml, P = 0.02). In peripheral blood of sepsis group patients, we found a significant increase of VEGF-A compared to controls (196.0 ± 70.5 pg/ml vs 59.6 ± 8.5 pg/ml, P = 0.02). In the cord blood plasma, eight miRNAs had significantly differential expression (P &lt; 0.05), four miRNAs were up-regulated and four miRNAs down-regulated. In peripheral blood plasma, all nine miRNAs with significant differential expression were up-regulated. In conclusion, in early-onset neonatal sepsis, IL-18 and VEGF-A might be considered in diagnostic workup. Early-onset sepsis in preterm newborns is associated with significant changes in the circulating miRNA pattern.
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a kojenec $7 D007223
650    12
$a mikro RNA $x genetika $7 D035683
650    12
$a novorozenecká sepse $x diagnóza $7 D000071074
650    _2
$a interleukin-18 $7 D020382
650    _2
$a vaskulární endoteliální růstový faktor A $7 D042461
650    _2
$a biologické markery $x metabolismus $7 D015415
650    12
$a sepse $x diagnóza $x genetika $7 D018805
650    _2
$a zánět $7 D007249
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mojžíšek, Marek $u Neonatal Unit, Department of Obstetrics and Gynaecology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $7 xx0327811
700    1_
$a Pánek, Martin, $u Department of Neonatology, Masaryk Hospital Ústí nad Labem, Krajská zdravotní, Ústí nad Labem, Czech Republic $d 1974- $7 mzk2006337208
700    1_
$a Haluzík, Martin, $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic $d 1970- $7 xx0000707
700    1_
$a Živný, Jan $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic. jzivny@LF1.cuni.cz $7 xx0115576
700    1_
$a Janota, Jan, $u Department of Neonatology, Thomayer University Hospital, Prague, Czech Republic. jan.janota@fnmotol.cz $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic. jan.janota@fnmotol.cz $u Neonatal Unit, Department of Obstetrics and Gynaecology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic. jan.janota@fnmotol.cz $d 1968- $7 stk2007405368
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 69, č. 5-6 (2023), s. 173-180
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38583178 $y Pubmed
910    __
$a ABA008 $b A 970 $c 89 $y p $z 0
990    __
$a 20240509 $b ABA008
991    __
$a 20250121094617 $b ABA008
999    __
$a ok $b bmc $g 2247162 $s 1218419
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 69 $c 5-6 $d 173-180 $e - $i 0015-5500 $m Folia biologica $n Folia Biol (Praha) $x MED00011004
GRA    __
$a NU20-07-00109 $p Agentura Pro Zdravotnický Výzkum České Republiky
LZP    __
$b NLK138 $a Pubmed-20240509

Find record

Citation metrics

Archiving options